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conduit) surgery: An assessment using computational modeling
Elias Balaras, PhD,a K. S. Cha, PhD,a Bartley P. Griffith, MD,b and James S. Gammie, MDb
Background: Aortic valve bypass surgery treats aortic valve stenosis with a valve-containing conduit that con-
nects the left ventricular apex to the descending thoracic aorta. After aortic valve bypass, blood is ejected from the
left ventricle via both the native stenotic aortic valve and the conduit. We performed computational modeling to
determine the effects of aortic valve bypass on aortic and cerebral blood flow, as well as the effect of conduit size
on relative blood flow through the conduit and the native valve.
Methods: The interaction of blood flow with the vascular boundary was modeled using a hybrid Eurelian–La-
grangian formulation, where an unstructured Galerkin finite element method was coupled with an immersed
boundary approach.
Results:Ourmodel predicted native (stenotic) valve to conduit flow ratios of 45:55, 52:48, and 60:40 for conduits
with diameters of 20, 16, and 10 mm, respectively. Mean gradients across the native aortic valve were calculated
to be 12.5, 13.8, and 17.6 mmHg, respectively. Post–aortic valve bypass cerebral blood flowwas unchanged from
preoperative aortic valve stenosis configurations and was constant across all conduit sizes. In all cases modeled,
cerebral blood flow was completely supplied by blood ejected across the native aortic valve.
Conclusions: An aortic valve bypass conduit as small as 10 mm results in excellent relief of left ventricular out-
flow tract obstruction in critical aortic valve stenosis. The presence of an aortic valve bypass conduit has no effect
on cerebral blood flow. All blood flow to the brain occurs via antegrade flow across the native stenotic valve; this
configuration may decrease the long-term risk of cerebral thromboembolism.680 The Journal of Thoracic and Cardiovascular SuAS populations. AVB surgery relieves the left ventricular
outflow obstruction of aortic stenosis through the construc-
tion of a second outflow tract from the left ventricle. A
Dacron conduit containing a bioprosthetic valve originates
at the left ventricular apex and terminates at a right angle to
the descending thoracic aorta (Figure 1). Potential advan-
tages of AVB compared with conventional AVR include
avoidance of (redo) sternotomy in the presence of patent
coronary bypass grafts; avoidance of aortic crossclamping,
cardiopulmonary bypass, and cardioplegic arrest; and a low
likelihood of postoperative heart block and patient–pros-
thesis mismatch.6 Although AVB is known to be a durable
operation, with some patients surviving more than 247 and
25 (personal communication, John W. Brown) years, to
date the circulatory physiology of AS treated with an
AVB conduit has been poorly characterized. We have
now used computational fluid dynamic (CFD) modeling
to answer key questions about the circulatory system after
AVB surgery. The goals of this study were to answer the
following questions: (1) What is the relative blood flow
through the native stenotic valve and the conduit, and
what are the key determinants of this distribution? (2)
Does AVB surgery relieve the left ventricular outflow tract
obstruction of critical AS? (3) Does CFD modeling accu-
rately predict gradients across the native (stenotic) aortic
valve after AVB surgery? (4) Is cerebral blood flow sup-
plied from antegrade flow through the native aortic valve,
via the conduit, or a combination of both? (5) Is cerebralSurgical aortic valve replacement (AVR) improves quality
of life and extends survival in most patients with symptom-
atic aortic stenosis (AS). Although isolated AVR can be
performed with an acceptable operative mortality,1,2 the re-
quirement for cardiopulmonary bypass, median sternotomy,
aortic crossclamping, valve debridement, and cardioplegic
cardiac arrest confers risks of morbidity and mortality to
patients undergoing conventional AVR. These risks are
particularly acute in high-risk subpopulations including the
elderly and patients with previous cardiac surgery, cerebro-
vascular disease, and concomitant calcific aortic disease.2-4
There is growing evidence that the majority of patients
with symptomatic AS are never considered for surgery as
a result of real and perceived risks of conventional AVR,
despite the fact that unoperated symptomatic AS carries
a dismal prognosis.5
Aortic valve bypass (AVB) surgery is an alternative to
conventional aortic valve replacement and can extend the
benefits of surgical relief of aortic stenosis to high-risk
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ALE ¼ arbitrary Lagrangian-Eulerian
AS ¼ aortic stenosis
AVB ¼ aortic valve bypass
AVR ¼ aortic valve replacement
blood flow unchanged after the treatment of AS with an
AVB?
METHODS
Problem Formulation and Numerical Method
To investigate the extensive parametric space that directly affects the
local blood flow after AVB surgery, we performed a series of computations
on an idealized 2-dimensional configuration of the heart and great vessels. A
sketch of the geometry is shown in Figure 2. The model includes an ideal-
ization of the left ventricle followed by a curved channel that represents the
aortic arch. The brachiocephalic, left common carotid, and left subclavian
arteries arise from the aortic arch. The mitral, aortic, and conduit valves
are included and are represented by plates with 0 thickness. Blood flow is
driven by the motion of the ventricular walls. The dimensions of the overall
setup, including the conduit, are representative of a typical clinical scenario
and are based on clinical experience and measurements in normal subjects.6
The fluid flow in the left ventricle and the surrounding vessels is gov-
erned by the Navier-Stokes equations:
V,u ¼ 0 (1)
vu
vt
þ ~u,Vu ¼Vpþ vV2uþ f ; (2)
where u is the velocity vector, p is the pressure normalized by the fluid den-
sity, v is the kinematic viscosity, f is a body force term, and u˜¼ uug is the
fluid velocity relative to a grid moving with velocity, ug. To solve Equations
(1) and (2) for the geometry given above, which includes complex moving
boundaries, a hybrid ALE (arbitrary Lagrangian-Eulerian)/immersed
boundary formulation has been developed. The basic solver uses an ALE/
finite-element formulation, which employs an efficient, explicit, fractional
4-step method allowing for the use of equal interpolation spaces for the pres-
sure and velocity fields.8 The spatial discretization is done using a Galerkin
method, where an explicit Lax–Wendrof-type scheme is used for the con-
vective terms to prevent checkerboard pressure oscillations. Details on the
overall formulation and its validation for a variety of prototypical fluid
and fluid–structure interaction problems can be found in Cha8 and Balaras.9
The above solver works well on complex geometries with relatively small
boundary motion but may become inefficient in cases with very large dis-
placements/deformations. The motion of the ventricular walls, for example,
could be accommodated by simply deforming the grid to conform to the new
location of the boundary at each time step. The motion of the valve leaflets
on the other hand, which undergo large rotational displacements and come
in contact with other stationary or moving boundaries, would require fre-
quent regeneration of the overall grid. As a result, grid quality as well as
accuracy and efficiency of the overall solver are difficult to preserve. To
overcome this problem, the effect of the leaflet motion on the flow is intro-
duced by an immersed boundary formulation. In such case, the requirement
for the grid to conform to the moving boundary is relaxed, and the boundary
conditions are enforced using a forcing function, f. The overall method is an
extension of our previous work on immersed boundary methods for struc-
tured Cartesian and cylindrical coordinate grids to fully unstructured
grids.9,10 In the present implementation, an arbitrary, 2-dimensional, im-
The Journal of Thoracic and Cmersed body is represented by a series of Lagrangian marker particles. At
each time step, the relation between the marker particles and the underline
finite element grid is identified and the forcing function, f in Equation (2), is
constructed in a way that the desired boundary conditions are satisfied. The
overall approach maintains second-order accuracy in space and time.
Computational Setup and Parametric Space
The primary objective of the series of computations reported in the pres-
ent study is to investigate how a valve-containing conduit implanted during
AVB surgery impacts the overall flow patterns in the surrounding great ves-
sels.We studied the following configurations: case I: normal; case II : severe
AS; cases III–V: severe AS with AVB conduit diameters of 20, 16, and 10
mm, respectively (Table 1, Figure 2). The conduit valve was also scaled
down by the same factor. Blood flow is driven by the simple harmonic
motion of the ventricular walls. The motion of the valves is imposed and
is based on earlier, highly detailed, fully 3-dimensional simulations of the
flow past prosthetic valves.10 A typical computational grid is shown in
Figure 3 and consists of approximately 125,000 elements. The overall
grid continuously deforms in order to conform to the moving ventricular
walls. This requirement, however, is relaxed for the case of the valves,
and their motion is introduced using the immersed boundary formulation
discussed above. All vascular boundaries were assumed to be rigid for all
calculations and the no-slip condition was applied.
In Figure 4, the ventricular motion during 1 cardiac cycle is shown to-
gether with the resulting flow rate through the aortic and mitral valves
FIGURE 1. Aortic valve bypass.
ardiovascular Surgery c Volume 137, Number 3 681
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DFIGURE 2. Simplified, 2-dimensional representation of the left ventricle and surrounding vessels. A, Reference configuration. Dav, Diameter of stenotic
aortic valve orifice ¼ 9 mm. B, Configuration after aortic valve bypass surgery for aortic stenosis. For all cases considered, a ¼ 90 and the diameters of
the innominate, left carotid, subclavian, and mitral inflow tract are 14, 8, 8, and 30 mm, respectively.and the valved conduit. The instant opening and closing time for each valve
is also indicated in the figure. The simple harmonic motion of the ventricular
wall allowed for a straightforward implementation of the valve kinematics
and results in flow rate variations that are in broad qualitative agreement
with the clinical data.
For all cases, the native aortic valve is assumed to have an 80% area ste-
nosis. Assuming that a healthy valve has an area of approximately 3.5 cm2,
for example, an 80% area stenosis is equivalent to an aortic valve area of
0.65 cm2. In all 4 configurations, a constant pressure boundary condition
has been used. Blood is assumed to be a Newtonian fluid with density
r¼ 1.1 g/cm3 and viscosity n¼ 0.035 P. The pick Reynolds number (based
on the average velocity,Ub, and the diameter of the aorta), a nondimensional
number characterizing the relative importance of viscous to inertial effects,
is approximately 4000. For all cases listed in Table 1, the computations were
initialized with quiescent flow and integrated in time until a quasi-periodic
state was reached and the effects of initial conditions were eliminated (typ-
ically 3 to 4 cycles). All results are presented for the cardiac cycles after this
stage.
Echocardiography
Quantitative Doppler echocardiography was performed on all patients
prior to hospital dismissal. Standardized evaluation included calculation
of mean gradients across the native (stenotic) aortic valve and was per-
formed in accordance with the American Society of Echocardiography’s
standardized reporting recommendations.11 A total of 17 patients with
20-mm conduits were available for echocardiographic assessment.
RESULTS
In Table 2, the mean native aortic valve pressure gradients
for the configurations considered are listed. Echocardio-
graphically determined mean transvalvular gradients for pa-
tients with severe symptomatic AS are from reference values
in the literature.6 For consistency, we used the same ap-
proach used in echocardiography (the modified Bernoulli
equation) to compute aortic valve pressure gradients.12,13
The mean velocity at the valve is computed by averaging
the computed velocity in the cross-sectional area. In order to
perform direct comparisons with the clinical data, all values
in Table 2 are scaled to the corresponding gradient from the682 The Journal of Thoracic and Cardiovascular Surgcase of severe untreated AS. For severe AS (80% stenosis,
aortic valve area ¼ 0.65 cm2) treated with a 20-mm AVB
conduit, our model predicts a mean native (stenotic) aortic
transvalvular gradient of 12.5 mm Hg. In our clinical expe-
rience to date with a 20-mm AVB conduit with a nominal-
sized 21 stentless porcine bioprosthetic valve (n ¼ 17), the
mean native (stenotic) transvalvular gradient determined
echocardiographically was 10.5 6mmHg, which is within
19% of the value predicted from the computational model.
When the diameter of the AVB conduit is decreased step-
wise to 16 then to 10 mm, our simulations predict mean gra-
dients of 13.8 and 17.6 mm Hg, respectively.
Figure 5 demonstrates blood flow through the native
valve, the conduit, and the 3 aortic arch vessels for cases I
to V. All flows are normalized to the peak systolic flow in
case II,Qo, which represents untreated severe aortic stenosis.
For case III (severe AS treated with a 20-mmAVB conduit),
the ratio of the total amount of blood flow through the native
stenotic aortic valve during the cardiac cycle to that of the
conduit is 45:55. As the conduit size is reduced in cases
IV and V, the corresponding ratios are 52:48 and 60:40,
respectively.
Blood flow to the 3 aortic arch vessels was minimally
affected by the presence or size of the AVB conduit. In
case II, for example, which represents untreated severe aortic
stenosis, peak blood flow through the brachiocephalic, left






I, Normal 0 No conduit
II, AS 80 No conduit
III, ASþ20 mm AVB 80 20
IV, ASþ16 mm AVB 80 16
V, ASþ10 mm AVB 80 10
AS, Aortic stenosis; AVB, aortic valve bypass; D, diameter.ery c March 2009
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DFIGURE 3. A, Snapshot of the computational grid (only a fraction of the grid points are plotted for clarity) for case II. B, Detail of the grid around the aortic
valve. Notice that the grid does not follow the surface valve. C, Detail of the grid around the moving part of the ventricular boundary.carotid, and subclavian arteries was 0.29Qo, 0.18Qo, and
0.18Qo, respectively. For all cases with the AVB conduit,
the corresponding flow rates were unchanged (flow variation
less than 3% from reference).
In Figure 6, instantaneous flow patterns and velocities for
cases II (untreated aortic stenosis), III (20-mm conduit),
and V (10-mm conduit) are compared during peak systole.
Isocontours of the V velocity component (along the axis of
the descending aorta) are shown. In all cases, a strong jet
through the native stenotic aortic valve can be observed.
As expected and consistent with our hypothesis that the
presence of an AVB conduit relieves the left ventricular
outflow tract obstruction of AS, the jet velocity decreases
substantially after insertion of the AVB conduit: the
maximum velocity is 0.51UIImax (where U
II
max is the max-
imum velocity in case II, untreated aortic stenosis) and
0.62UIImax for cases III and V, respectively. The velocity
magnitude in the middescending aorta is also affected,
and in all post-AVB cases, it is approximately 6 to 7 times
smaller compared with the untreated aortic stenosis model.
For the 2 cases with the larger conduit size (cases III and
IV), there is also some flow reversal in the descending
aorta immediately cephalad to the distal insertion of the
AVB conduit as seen in the inserts at the lower part of Fig-
ure 6. This can be seen more clearly in Figure 7 whereThe Journal of Thoracic and Cflow patterns in the region of the distal anastomosis are
shown. For case III (20-mm AVB conduit), there is rever-
sal of flow in the descending aorta immediately cephalad
to the distal insertion of the AVB, with a small proportion
of conduit flow directed upward in the descending aorta,
and for case V (10-mm conduit), the flow coming from
the native valve merges with the one coming out of the
conduit and no flow reversal is observed. The 20-mm con-
duit model is consistent with our clinical experience, where
we have observed flow reversal patterns similar to those
created with this model on postoperative magnetic reso-
nance imaging. In our CFD model, all blood flow to the
brain (ie, flow to the innominate and left carotid arteries)
is completely supplied from antegrade flow across the ste-
notic aortic valve, even in the presence of a large (20-mm
diameter) AVB conduit.
DISCUSSION
Although AVB surgery has been performed clinically for
more than 50 years, there have been no efforts to character-
ize the circulatory physiology after insertion of a valved con-
duit from the apex of the left ventricle to the descending
aorta. The present investigation, using sophisticated CFD
modeling, has allowed us to answer some basic questions
about the nature and determinants of the circulation afterardiovascular Surgery c Volume 137, Number 3 683
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of a valved conduit from the apex of the left ventricle to the
descending thoracic aorta results in highly effective relief of
left ventricular outflow tract obstruction. The predicted
mean gradient across the native (stenotic) aortic valve after
insertion of an AVB conduit in our model (with a 20-mm di-
ameter AVB conduit) was 12.5 mmHg, which is remarkably
close to the echocardiographically determined value of 10.5
 6.0 mm Hg as measured in 17 clinical cases. These values
compare favorably to gradients measured across biopros-
thetic and mechanical replacement valves after clinically
successful conventional aortic valve replacement surgery
and reinforce our clinical perception that AVB surgery re-
sults in reliable symptom relief and prolongation of sur-
vival.14-18
AVB surgery results in 2 outflow tracts for egress of blood
from the left ventricle. Adequacy of cerebral blood flow is
a frequent concern when this approach is considered. The
FIGURE 4. Imposed displacement of the ventricular walls during 1 car-
diac cycle. Also shown are the resulting flow rates through the native aortic
valve (Qa), conduit (Qc), and mitral valve (Qm). All flow rates are normal-
ized with the peak flow rate through the mitral valve, and time with the du-
ration of the cardiac cycle. The opening and closing times for all 3 valves are
also indicated in the figure. AO, Opening of the aortic valve; AC, closing of
the aortic valve; CO, opening of the conduit valve; CC, closing of the con-
duit valve;MO, opening of the mitral valve;MC, closing of the mitral valve.684 The Journal of Thoracic and Cardiovascular Surpresent studies demonstrate no appreciable change in cere-
bral blood flow (ie, through the innominate and left carotid
arteries) in all AVB configurations modeled. Because cere-
bral blood flow is a function of resistance in the cerebral cir-
culation and pressure in the aorta and aortic pressure is
normal after AVB surgery, these results are not surprising.
The long-term risk of stroke after conventional aortic
valve replacement surgery is a significant concern and is
of particular importance in younger patients as that risk is
amortized over the individual’s lifetime. Both mechanical
and bioprosthetic aortic valves are associated with thrombo-
embolism risk between 0.5% and 2.0% per year.19 At
15-year follow-up, approximately 20% of patients having
aortic valve replacement had suffered a stroke in 1 large
study.20 In our clinical experience, thromboembolism is
very uncommon in midterm follow-up after AVB surgery,
despite a population at very high risk of stroke. We hypoth-
esize that AVB surgery confers protection from stroke be-
cause all blood flow to the brain is directed across the
native (stenotic) valve, rather than across a prosthesis as is
the case after conventional AVR. Thrombus that forms on
the bioprosthesis cannot embolize to the brain. These com-
putational fluid dynamic modeling studies support this hy-
pothesis: in all cases examined, blood flow to the brain
was antegrade across the native (stenotic) aortic valve.
Even in case II (conduit size 20 mm), where the most signif-
icant flow reversal in the descending aorta occurs, all blood
flow to the innominate and left carotid arteries was supplied
in an antegrade fashion.
As we decreased the size of the AVB conduit in our
model, we found that it had a relatively small effect on the
gradient across the native (stenotic) valve. Reduction of
the diameter from 20 mm to 10 mm, for example, increased
the gradient across the native valve by 25% (mean gradient
increased from 12.5 mm Hg to 17.6 mm Hg). This value is
still well below that of untreated aortic stenosis, suggesting
that a smaller conduit compared to that which is currently
used in clinical practice might be adequate to treat aortic ste-
nosis.
Due to the number of approximations involved in our
model, care must be taken in relating these results to clinical
practice. The curvature of the conduit, size and type of valve,
angle of proximal and distal anastomosis, degree of aortic in-
sufficiency, and cardiac output are among the parametersTABLE 2. Native aortic valve gradients
Clinical data Numerical data (2-D)
Mean (mm Hg) Mean normalized Mean (mm Hg)y Mean normalized
Case II (80% stenosis) 43.0  7.0* 1 43.0 1
Case III (AVB, D ¼ 20 mm) 10.5  6.0* 0.24 12.5 0.29
Case IV (AVB, D ¼ 16 mm) — — 13.8 0.32
Case V (AVB, D ¼ 10 mm) — — 17.6 0.41
AVB, aortic valve bypass; D, diameter. *From Gammie et al.6 yThe numerical data are simply rescaled using the untreated native stenotic valve gradient as a reference.gery c March 2009
Balaras et al Acquired Cardiovascular DiseaseFIGURE 5. Relative blood flow through the native valve, the conduit, and the 3 aortic arch vessels as a function of time. A, Case II (untreated severe aortic
stenosis). B, Case III (severe aortic stenosis with aortic valve bypass [AVB] conduit diameter 20 mm). C, Case IV (severe aortic stenosis with AVB conduit
diameter 16 mm). D, Case V (severe aortic stenosis with AVB conduit diameter 10 mm). All flows are normalized to the peak value from case II.The Journal of Thoracic and C
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Dideal conduit diameter, size, shape, and anastomosis loca-
tion.
These CFD studies have characterized the circulatory
physiology after AVB surgery. We have demonstratedthat can influence this outcome and have not been incorpo-
rated in the present 2-dimensional model. Further 3-dimen-
sional experimental and numerical studies are necessary to
provide more precise quantitative answers regarding theFIGURE 6. Snapshot of peak systolic flow. Isolines of the velocity component along the y-axis (axis aligned with descending aorta) are shown. The insert in
each case shows streak lines indicating the flow direction.ardiovascular Surgery c Volume 137, Number 3 685
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DFIGURE 7. Snapshot of the flow at peak systole. Isolines of the vorticity are shown. Superimposed are stream traces indicating the flow direction.686 The Journal of Thoracic and Cardiovascular Sur7. Freeman LJ, de Leval MR, Tsang VT. The longest functioning apical left
ventricular to descending aortic valve conduit. Ann Thorac Surg. 2005;79:
1420.
8. Cha KS.Finite element analysis of unsteady separated flows around a moving
body. PhD thesis. Chonnam National University: Gwangju, South Korea; 2004.
9. Balaras E. Modeling complex boundaries using an external force field on fixed
Cartesian grids in large-eddy simulations.Computers & Fluids. 2004;33:375-404.
10. Yang JM, Balaras E. An embedded-boundary formulation for large-eddy simula-
tion of turbulent flows interacting with moving boundaries. J Comput Phys. 2006;
215:12-40.
11. American Society of Echocardiography. Recommendations for a standardized re-
port for adult transthoracic echocardiography. Available at www.asecho.org/14a/
pages/index.cfm?pageid¼3317. Accessed October 8, 2008.
12. Callahan MJ, Tajik AJ, Su-Fan Q, Bove AA. Validation of instantaneous pressure
gradients measured by continuous-wave Doppler in experimentally induced aortic
stenosis. Am J Cardiol. 1985;56:989-93.
13. Hegrenaes L, Hatle L. Aortic stenosis in adults. Non-invasive estimation of pres-
sure differences by continuous wave Doppler echocardiography. Br Heart J.
1985;54:396-404.
14. Dalmau MJ, Maria Gonzalez-Santos J, Lopez-Rodriguez J, Bueno M,
Arribas A, Nieto F. One year hemodynamic performance of the Perimount
Magna pericardial xenograft and the Medtronic Mosaic bioprosthesis in the
aortic position: a prospective randomized study. Interact Cardiovasc Thorac
Surg. 2007;6:345-9.
15. Tasca G, Brunelli F, Cirillo M, Dalla TombaM,Mhagna Z, Troise G, et al. Impact
of the improvement of valve area achieved with aortic valve replacement on the
regression of left ventricular hypertrophy in patients with pure aortic stenosis.
Ann Thorac Surg. 2005;79:1291-6; discussion 96.
16. Riess FC, Bader R, Cramer E, Hansen L, Kleijnen B,Wahl G, et al. Hemodynamic
performance of the Medtronic Mosaic porcine bioprosthesis up to ten years. Ann
Thorac Surg. 2007;83:1310-8.that AVB conduit insertion effectively relieves native aor-
tic valve stenosis, that cerebral blood flow is quantitatively
unchanged after placement of an AVB, that all cerebral
blood flow arises from the native left ventricular outflow
tract, and that smaller conduit diameters than currently
used clinically are associated with adequate relief of aortic
stenosis.
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